Arvydas Ambrozaitis
- Pharmaceutical Science top 5%
- Hepatology top 5%
- Hepatitis C virus research 12
- Epidemiology top 5%
- Influenza Virus Research Studies 17
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 9
- Respiratory viral infections research 8
- Virology top 10%
- Infectious Diseases top 10%
- Viral Infections and Vectors 5
-
- Vector-borne infectious diseases 5
-
- Emergency and Acute Care Studies 3
- Co-authors
- Françoise WeberGiancarlo IcardiPierre Van DammeTomas KačergiusStefan GravensteinAlvydas Pranas LaiškonisDan EricsonVytautė Pečiulienė
- Journals
- Vaccine (4 papers)Journal of the American Medical Directors Association (4 papers)Journal of Hepatology (2 papers)
- Partner nations
- LithuaniaUnited KingdomUnited States
In The Last Decade
Arvydas Ambrozaitis
40 papers receiving 815 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 105
- Hepatology 130
- Epidemiology 512
- Virology 68
- Infectious Diseases 215
Countries citing papers authored by Arvydas Ambrozaitis
This map shows the geographic impact of Arvydas Ambrozaitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvydas Ambrozaitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvydas Ambrozaitis more than expected).
Fields of papers citing papers by Arvydas Ambrozaitis
This network shows the impact of papers produced by Arvydas Ambrozaitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvydas Ambrozaitis. The network helps show where Arvydas Ambrozaitis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arvydas Ambrozaitis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2021 | 8 | |
| 3 | 2019 | 8 | |
| 4 | 2018 | 6 | |
| 5 | 2017 | 3 | |
| 6 | 2016 | 3 | |
| 7 | 2014 | 36 | |
| 8 | 2013 | 12 | |
| 9 | 2010 | 64 | |
| 10 | 2009 | 143 | |
| 11 | 2009 | 29 | |
| 12 | 2008 | 1 | |
| 13 | 2006 | 97 | |
| 14 | 2006 | 5 | |
| 15 | 2006 | 35 | |
| 16 | 2005 | 29 | |
| 17 | 2005 | 38 | |
| 18 | 2005 | 3 | |
| 19 | 2003 | 3 | |
| 20 | 1995 | 26 |
About Arvydas Ambrozaitis
Arvydas Ambrozaitis is a scholar working on Hepatology, Epidemiology and Parasitology, having authored 43 papers that have together received 847 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (17 papers), Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (9 papers), Hepatitis B Virus Studies (9 papers), Respiratory viral infections research (8 papers), Vector-borne infectious diseases (5 papers), Viral Infections and Vectors (5 papers) and Emergency and Acute Care Studies (3 papers). The work is most often cited by research in Pharmaceutical Science (105 citations), Hepatology (130 citations) and Epidemiology (512 citations). Arvydas Ambrozaitis has collaborated with scholars based in Lithuania, United Kingdom and United States. Frequent co-authors include Françoise Weber, Giancarlo Icardi, Pierre Van Damme, Tomas Kačergius, Stefan Gravenstein, Alvydas Pranas Laiškonis, Dan Ericson, Vytautė Pečiulienė, Peter Shult and Narseta Mickuvienė. Their work appears in journals such as Vaccine, Journal of the American Medical Directors Association, Journal of Hepatology, Annals of the Rheumatic Diseases and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.